Patient Experience and Technical Success of Community Sleep Studies
Launched by PAPWORTH HOSPITAL NHS FOUNDATION TRUST · Jun 20, 2022
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
There is a study underway to develop a non-contact detector of breathing (SafeScan) as a new method of diagnosing obstructive sleep apnoea (OSA). There are a number of different methods already available to achieve this end but one proposed advantage of the new SafeScan device is that it will not affect sleep quality and because there are no measuring devices attached to the patient it is less likely that the signal will be lost in the night due to the normal movements of sleep. However there are no data available that quantify these factors as an issue for the current techniques and device...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient able to provide assent by completion of the Research Questionnaire Adult patients (≥ 18 years of age) Patients undergoing a home sleep study
- Exclusion Criteria:
- • Patients unable to complete questionnaires due to language or other barriers
About Papworth Hospital Nhs Foundation Trust
Papworth Hospital NHS Foundation Trust is a leading healthcare institution in the United Kingdom, renowned for its specialized services in cardiothoracic medicine and surgery. As a prominent clinical trial sponsor, the Trust is dedicated to advancing medical research and improving patient outcomes through innovative trials and studies. With a commitment to excellence in patient care, Papworth Hospital collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to facilitate cutting-edge research that addresses critical health challenges. The Trust's experienced team of clinicians and researchers is focused on delivering high-quality evidence that contributes to the advancement of healthcare practices and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials